Tenofovir Alafenamide Fumarate | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Grow Your Pharma Business Digitally

X

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Tenofovir Alafenamide Fumarate
US Exclusivities

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Tenofovir Alafenamide Fumarate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 25 USDMF, 7 EU WC, 4 KDMF, 12 NDC API, 23 Listed Suppliers, $ API Reference Price

45 API Suppliers
25 USDMF
7 EU WC
4 KDMF
12 NDC API
23 Listed Suppliers
$ API Reference Price

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

15 FDF Dossiers, 14 FDA Orange Book, 1 Listed Dossiers

15 FDF Dossiers
14 FDA Orange Book
1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE, TABLET;ORAL - 120MG;EQ 15MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE, TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE, TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE

TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE
TABLET;ORAL - 120MG;EQ 15MG BASE
TABLET;ORAL - 200MG;EQ 25MG BASE
TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE
TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE
TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 5 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 3 Actylis, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 24 BASF, 5 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 3 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 20 Kerry, 10 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 10 Roquette, 2 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 3 Vasa Pharmachem

1 SPI Pharma
3 DKSH
5 Faran Shimi Pharmaceutical
1 Boai NKY Pharmaceuticals Ltd
4 Gangwal Healthcare
3 Nanjing Well Pharmaceutical
3 Actylis
1 Aeon Procare
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
24 BASF
5 Corel Pharma Chem
5 DFE Pharma
1 Finar
7 Gangwal Chemicals
3 Ideal Cures Pvt Ltd
1 Ingredion Pharma Solutions
20 Kerry
10 Microlex e.U
2 Nomisma Healthcare
2 Novo Excipients
2 Pharmatrans-Sanaq
5 Pluviaendo
3 Prachin Chemical
10 Roquette
2 Seppic
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
11 Sigachi Industries
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Fillers, Diluents & Binders, 23 Coating Systems & Additives, 19 Granulation, 16 Direct Compression, 16 Controlled & Modified Release, 15 Disintegrants & Superdisintegrants, 15 Thickeners and Stabilizers, 14 Solubilizers, 14 Lubricants & Glidants, 12 Topical, 7 Parenteral, 7 Co-Processed Excipients, 6 Film Formers & Plasticizers, 5 Taste Masking, 3 Surfactant & Foaming Agents, 3 Coloring Agents, 2 Rheology Modifiers, 2 Emulsifying Agents, 2 Chewable & Orodispersible Aids, 1 API Stability Enhancers

44 Fillers, Diluents & Binders
23 Coating Systems & Additives
19 Granulation
16 Direct Compression
16 Controlled & Modified Release
15 Disintegrants & Superdisintegrants
15 Thickeners and Stabilizers
14 Solubilizers
14 Lubricants & Glidants
12 Topical
7 Parenteral
7 Co-Processed Excipients
6 Film Formers & Plasticizers
5 Taste Masking
3 Surfactant & Foaming Agents
3 Coloring Agents
2 Rheology Modifiers
2 Emulsifying Agents
2 Chewable & Orodispersible Aids
1 API Stability Enhancers

DIGITAL CONTENT

8 News #PharmaBuzz

8 News #PharmaBuzz

MARKET PLACE

8 APIs

8 APIs

PATENTS & EXCLUSIVITIES

89 US Patents, 9 US Exclusivities

89 US Patents
9 US Exclusivities

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 2,977 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

9 All

01 9GILEAD SCIENCES INC

filter Product Reset all filters

9 All

01 7BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

02 1EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

03 1TENOFOVIR ALAFENAMIDE FUMARATE

filter Exclusivity Expiration Date Reset all filters

9 All

01 12025-10-17

02 12026-06-18

03 22027-02-23

04 12027-04-24

05 12028-10-07

06 12029-01-07

07 22031-02-23

filter Exclusivity Code Reset all filters

9 All

01 2I-942

02 1M-305

03 1NPP

04 1ODE-256

05 1ODE-378

06 1ODE-457

07 2ODE-468

Product Main Page

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-305

Exclusivity Expiration Date

2027-04-24

Application Number

210251

Product Number

1

Exclusivity Details

01

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

ELCC

Not Confirmed

GILEAD SCIENCES INC

U.S.A

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : M-305

Exclusivity Expiration Date : 2027-04-24

Application Number : 210251

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-256

Exclusivity Expiration Date

2026-06-18

Application Number

210251

Product Number

1

Exclusivity Details

02

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

ELCC

Not Confirmed

GILEAD SCIENCES INC

U.S.A

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : ODE-256

Exclusivity Expiration Date : 2026-06-18

Application Number : 210251

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-457

Exclusivity Expiration Date

2029-01-07

Application Number

208215

Product Number

2

Exclusivity Details

03

GILEAD SCIENCES INC

EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

ELCC

Not Confirmed

GILEAD SCIENCES INC

U.S.A

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : ODE-457

Exclusivity Expiration Date : 2029-01-07

Application Number : 208215

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2025-10-17

Application Number

208464

Product Number

1

Exclusivity Details

04

GILEAD SCIENCES INC

TENOFOVIR ALAFENAMIDE FUMARATE

ELCC

Not Confirmed

GILEAD SCIENCES INC

U.S.A

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : NPP

Exclusivity Expiration Date : 2025-10-17

Application Number : 208464

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-468

Exclusivity Expiration Date

2031-02-23

Application Number

210251

Product Number

2

Exclusivity Details

05

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

ELCC

Not Confirmed

GILEAD SCIENCES INC

U.S.A

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : ODE-468

Exclusivity Expiration Date : 2031-02-23

Application Number : 210251

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-942

Exclusivity Expiration Date

2027-02-23

Application Number

210251

Product Number

2

Exclusivity Details

06

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

ELCC

Not Confirmed

GILEAD SCIENCES INC

U.S.A

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : I-942

Exclusivity Expiration Date : 2027-02-23

Application Number : 210251

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-378

Exclusivity Expiration Date

2028-10-07

Application Number

210251

Product Number

2

Exclusivity Details

07

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

ELCC

Not Confirmed

GILEAD SCIENCES INC

U.S.A

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : ODE-378

Exclusivity Expiration Date : 2028-10-07

Application Number : 210251

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-468

Exclusivity Expiration Date

2031-02-23

Application Number

210251

Product Number

1

Exclusivity Details

08

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

ELCC

Not Confirmed

GILEAD SCIENCES INC

U.S.A

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : ODE-468

Exclusivity Expiration Date : 2031-02-23

Application Number : 210251

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GILEAD SCIENCES INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-942

Exclusivity Expiration Date

2027-02-23

Application Number

210251

Product Number

1

Exclusivity Details

09

GILEAD SCIENCES INC

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

ELCC

Not Confirmed

GILEAD SCIENCES INC

U.S.A

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Exclusivity Code : I-942

Exclusivity Expiration Date : 2027-02-23

Application Number : 210251

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!